[Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary

Alberto Cordero1, Vicente Bertomeu-Gonzalez2, José V Segura3

  • 1Departamento de Cardiología, Hospital IMED Elche, Elche, Alicante, España; Grupo de Investigación Cardiovascular, Universidad Miguel Hernández, Elche, Alicante, España; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, España.

Medicina Clinica
|May 31, 2024
PubMed

Insights

Artificial intelligence identified key factors predicting heart failure (HF) after acute coronary syndrome (ACS). An AI model created 15 risk patterns to forecast HF hospitalization probability, aiding patient management.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Predictive Analytics

Background:

  • Coronary heart disease is the primary cause of heart failure (HF).
  • Identifying patients at high risk for HF post-acute coronary syndrome (ACS) is crucial.
  • Artificial intelligence (AI) shows promise in predicting cardiovascular complications.

Purpose of the Study:

  • To develop a tool for identifying patients at higher risk of developing heart failure (HF) after an acute coronary syndrome (ACS).
  • To leverage artificial intelligence (AI) for predicting HF development in ACS patients.

Main Methods:

  • Utilized decision tree models based on recursive partitioning algorithms.
  • Included 7,097 consecutive patients discharged after ACS from two Spanish centers (2006-2017).
  • Collected clinical data and followed patients for a median of 53 months.

Main Results:

  • Identified eight key variables predicting HF hospitalization: HF at index hospitalization, diabetes, atrial fibrillation, glomerular filtration rate, age, Charlson index, hemoglobin, and left ventricular ejection fraction.
  • The AI-driven decision tree model generated 15 distinct clinical risk patterns.
  • Observed a 13.6% HF readmission rate among the cohort.

Conclusions:

  • AI effectively identified eight variables for predicting HF post-ACS.
  • The developed decision tree model provides 15 differentiated risk patterns for HF hospitalization probability.
  • An electronic application based on the model is freely available.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
79
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336